CH-Bioforce is the developer of the best biomass fractionation technology in the world.
CH-Bioforce Oy has raised $16.5M in total funding. The most recent round was Grant. The last funding was announced in March 2022.
CH-Bioforce Oy's investors include European Innovation Council, EISMEA, 100+ Accelerator.
CH-Bioforce Oy is headquartered in Espoo, Finland.
CH-Bioforce is the developer of the best biomass fractionation technology in the world.
CH-Bioforce Oy is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CH-Bioforce Oy — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/ch-bioforce-oy. Accessed July 20, 2026.
VCBacked. (2022). CH-Bioforce Oy — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ch-bioforce-oy
{{cite web |title=CH-Bioforce Oy — Funding & Investors |url=https://www.vcbacked.co/company/ch-bioforce-oy |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated